Multicentre SMS Study - FR

Ki vehet részt

• Patient suffering from a severely painful and/or disabling hip joint due to osteoarthritis, traumatic arthritis, developmental dysplasia of the hip, or avascular necrosis of the femoral head, and requiring a total hip replacement
• Patient who will receive a Medacta SMS femoral stem
• Patient agrees to comply with the study requirements
• Patient has signed the consent form
• Patient is affiliated with a social security system
• Patient aged 18 to 75 years

Ki nem vehet részt

• Osteomalacia for which the fixation of an uncemented implant is contraindicated
• Acute, systemic, or chronic infection. Skeletal immaturity
• Patient with metabolic disorders likely to impair bone formation when the fixation of an uncemented implant is contraindicated
• Patient suffering from muscle atrophy or neuromuscular disease
• Patient with an allergy to the implant material
• Participation in biomedical research
• Minor patient
• Protected adult patient
• Vulnerable individuals as defined by Article L1121-6 of the Public Health Code
• Pregnant or breastfeeding women
• Patient unable to express their non-opposition
• Patient refusing the collection of their personal data
• Grossly deformed anatomy (at the surgeon's discretion)
• Patient suffering from active rheumatoid arthritis or osteoporosis
• Any patient who cannot or does not wish to give their informed consent to participate in the study
• Patient whose prospects of regaining independent mobility would be compromised by known coexisting medical problems
• Any contraindication mentioned in the instructions for use of the investigational medical device